BridgeOne Capital
VC Fund
Longgang, China
BridgeOne Capital is a VC fund in Longgang focused on Medical and Health Care. Daohe Technology Investment focuses on investment in global new technology and application fields.
- Total investments:
- 8
- Last investment:
- Lead investor:
- 13%
Last updated:
For AI agents: llms.txt
Industries BridgeOne Capital invests in
Stages BridgeOne Capital invests in
Countries BridgeOne Capital invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
|
|||
4 more contacts available
Investment Focus
Industry
- Medical 3 (38%)
- Health Care 2 (25%)
- Art 1 (13%)
- Video 1 (13%)
- Fashion 1 (13%)
Stage
- Series A 3 (38%)
- Series B 3 (38%)
- Seed 1 (13%)
- Venture - Series Unknown 1 (13%)
Country
- China 4 (50%)
- Hong Kong 1 (13%)
- United States 1 (13%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Wang Chunyan
Founding Partner and CEO
|
Founding Partner and CEO | Total investments: 1 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
|
|
Cornerstone Robotics operates to improve the accessibility of high-end medical services in China. | $200M / Venture - Series Unknown / Nov 10, 2025 | |
|
|
VideoTutor is an AI-powered personalized learning platform that offers interactive video-based tutorials. | $11M / Seed / Oct 30, 2025 | |
|
|
ThunderBio Innovation engages in business includes tumor screening based on the digital biopsy technology of microfluidic chip, etc. | $14M / Series B / Jan 04, 2024 | |
|
|
Cornerstone Robotics operates to improve the accessibility of high-end medical services in China. | $110.3M / Series B / Jun 30, 2023 | |
|
|
Beino Bio is a China-based supplier of biopharmaceutical CDMO and cell culture media, providing process development and GMP production services for companies interested in introducing protein, cell therapy and gene therapy drugs to the Chinese and global markets. | Series A / Dec 21, 2021 | |
|
|
Keyto specializes in the production of key electrical and mechanical components for microfluid system controls. | Series B / Jan 22, 2021 | |
|
|
Goumee is a live-streaming fashion e-commerce platform. Goumee provides female fashion information services through a multi-channel network. | $14.1M / Series A / Mar 30, 2020 | |
|
Thorough Future
|
Using big data and artificial intelligence to provide pathology images with intelligent discriminations, diagnosis, prediction. | Series A |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does BridgeOne Capital invest in?
BridgeOne Capital invests primarily in Medical, Health Care and Art startups, most often at Series A and Series B stage. Most of the 8 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact BridgeOne Capital?
Public channels for BridgeOne Capital include the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at BridgeOne Capital?
The team at BridgeOne Capital includes Wang Chunyan (Founding Partner and CEO). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!